{"authors": [["Meikle", "Peter", "P", "Baker IDI Heart and Diabetes Institute, Melbourne, Australia."], ["Barlow", "Christopher", "C", "Baker IDI Heart and Diabetes Institute, Melbourne, Australia."], ["Nestel", "Paul", "P", "Baker IDI Heart and Diabetes Institute, Melbourne, Australia."], ["Barnes", "Elizabeth", "E", "NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia."], ["Kirby", "Adrienne", "A", "NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia."], ["Thompson", "Peter", "P", "Sir Charles Gairdner Hospital, Perth, Australia."], ["Sullivan", "David", "D", "Royal Prince Alfred Hospital, Sydney, Australia."], ["Alshehry", "Zahir", "Z", "Baker IDI Heart and Diabetes Institute, Melbourne, Australia."], ["Mellett", "Natalie", "N", "Baker IDI Heart and Diabetes Institute, Melbourne, Australia."], ["Huynh", "Kevin", "K", "Baker IDI Heart and Diabetes Institute, Melbourne, Australia."], ["Mcconville", "Malcolm", "M", "University of Melbourne, Melbourne, Australia."], ["Wong", "Gerard", "G", "Baker IDI Heart and Diabetes Institute, Melbourne, Australia."], ["Kingwell", "Bronwyn", "B", "Baker IDI Heart and Diabetes Institute, Melbourne, Australia."], ["Simes", "John", "J", "NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia."], ["Tonkin", "Andrew", "A", "Monash University, Melbourne, Australia."]], "text": "", "id": "29365917", "date": "2017-08-12", "title": "Decreases in plasma phosphatidylinositol species partially explain the reduction in cardiovascular events after pravastatin therapy in secondary prevention.", "doi": "10.1016/j.atherosclerosis.2017.06.776", "journal": ["Atherosclerosis", "Atherosclerosis"]}